Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$17,224,601
+$6,525,133 QoQ
Shares Held
86,274
+52.5% QoQ
Ownership
0.430%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 70.9947376961773.ToString("F0")%
Shared 0.ToString("F0")%
None 29.005262303822704.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. LGND ranks #61 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,224,601 | 86,274 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $10,699,468 | 56,590 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $7,035,644 | 39,718 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $4,321,542 | 38,015 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,248,915 | 40,412 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $4,046,089 | 37,761 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,650,178 | 56,451 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $5,373,425 | 63,772 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $3,655,436 | 50,006 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $4,490,816 | 62,879 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $3,608,079 | 60,215 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,576,419 | 35,734 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,537,424 | 48,089 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $2,594,044 | 38,833 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,154,359 | 40,105 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,201,220 | 39,549 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,916,319 | 41,558 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $3,846,851 | 39,923 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $3,482,387 | 40,068 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $4,667,105 | 57,027 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $4,318,907 | 45,413 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,059,867 | 49,321 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $2,716,290 | 45,680 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $1,593,040 | 22,831 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $1,126,181 | 24,825 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||